Ultra-long-term EEG Monitoring in PwID

Inclusion Criteria

• •Patients:
• •Adults over 18 years old
• •Clinical diagnosis of epilepsy, considered pharmacoresistant
• •Clinical diagnosis of mild to moderate ID based on the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) and the International Statistical Classfication of Diseases and Related Health Problems (11th ed; ICD-11; World Health Organisation, 2022).Patient has the capacity to consent to take part in the study, and does so
• •Able to tolerate the dummy device (device worn for at least 40% of a 1-2 week test period)
• •Family member / carer:
• •Family member/carer is willing to keep a routine seizure diary for the course of the study
• •Retrospective seizure diary data available for the proceeding last 6 months
• •According to family member, carer, or clinical record, the participant is having at least monthly 'episodes of interest' (it may be unclear whether these are epileptic or behavioural episodes)
• •Agree to participate to the study, and support study activities and comply to these
• •Healthcare professional:
• •PwID recommended by their epileptologist for long-term EEG monitoring
• •Agree to participate to the study, and support study activities and comply to these